J Neurol Surg B Skull Base 2021; 82(03): 295-302
DOI: 10.1055/s-0039-1700498
Original Article

Multidisciplinary Team Care in the Surgical Management of Pituitary Adenoma

1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
,
Agnish Nayak
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
,
Mark Winder
2   Department of Neurosurgery, St Vincent's Hospital, Sydney, Australia
,
Benjamin Jonker
2   Department of Neurosurgery, St Vincent's Hospital, Sydney, Australia
3   Department of Neurosurgery, Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
4   Brain and Mind Centre, University of Sydney, Camperdown, Sydney, New South Wales, Australia
,
Raquel Alvarado
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
,
Henry Barham
5   Sinus and Nasal Specialists of Louisiana, Louisiana, United States
,
Ann McCormack
6   Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, Australia
7   St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia
8   Department of Endocrinology, St Vincent's Hospital, Sydney, Australia
,
Richard J. Harvey
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
9   Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
› Institutsangaben

Abstract

Objective Despite multidisciplinary care being commonly recommended, there remains limited evidence supporting its benefits in pituitary disease management. This study aimed to assess the impact of multidisciplinary care in pituitary surgery.

Methods A retrospective cohort study was performed comparing pituitary surgery outcomes among consecutive patients within a quaternary referral center in 5 years before and after introduction of a multidisciplinary team (MDT). Primary outcomes were endocrine (transient diabetes insipidus [DI], syndrome of inappropriate antidiuretic hormone [SIADH], and new hypopituitarism) and surgical (cerebrospinal fluid [CSF] leak, epistaxis, intracranial hemorrhage, and meningitis) complications, length of hospital stay, and intrasellar residual tumor.

Results 279 patients (89 pre-MDT vs. 190 post-MDT) were assessed (age 54 ± 17 years, 48% female). Nonfunctioning adenomas were most common (54%). In the post-MDT era, more clinically functioning tumors (42 vs. 28%, p = 0.03) were treated. Transient DI and SIADH occurred less often post-MDT (20 vs. 36%, p < 0.01 and 18 vs. 39%, p < 0.01), as well as new hypothyroidism (5 vs. 15, p < 0.01). Hospital stay was shorter post-MDT (5[3] vs. 7[5] days, p < 0.001) and intrasellar residuals were less common (8 vs. 35%, p < 0.001). Complications were more frequent pre-MDT independent of tumor size, hormone status, and surgical technique (odds ratio [OR] = 2.14 [1.05–4.32], p = 0.04).

Conclusion Outcomes of pituitary surgery improved after the introduction of an MDT. Pituitary MDTs may benefit both patients and the health system by improving quality of care and reducing hospital stays.



Publikationsverlauf

Eingereicht: 15. Juni 2019

Angenommen: 13. September 2019

Artikel online veröffentlicht:
21. Oktober 2019

© 2019. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK?. Lancet Oncol 2006; 7 (11) 935-943
  • 2 Guidelines for Developing HealthOne NSW Services. Accessed September 27, 2019. at: https://www.health.nsw.gov.au/healthone/Documents/honswguidedevelop_11.pdf
  • 3 National Institute for Health and Clinical Excellence. Improving Outcomes for People with Brain and Other CNS Tumours: The Manual. London: National Institute for Health and Clinical Excellence; 2006
  • 4 Linck P, Priedane E, Hughes DA, Edwards RT. Analysis of the Potential Economic Impact of the Guidance: ‘Improving Outcomes for People with Brain and Other CNS Tumours. London, UK: National Institute for Health and Clinical Excellence; 2006
  • 5 Taylor C, Munro AJ, Glynne-Jones R. et al. Multidisciplinary team working in cancer: what is the evidence?. BMJ 2010; 340: c951
  • 6 Rainsbury JW, Ginn E, De R, Ahmed SK, Irving RM. The skull base multidisciplinary team approach: our experience over the first year in three hundred and seventeen patients. Clin Otolaryngol 2012; 37 (06) 470-474
  • 7 Casanueva FF, Barkan AL, Buchfelder M. et al; Pituitary Society, Expert Group on Pituitary Tumors. Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 2017; 20 (05) 489-498
  • 8 Inder WJ, Alford FP. Pituitary masses: the importance of a multidisciplinary approach. Med J Aust 2007; 187 (09) 522-523
  • 9 Charalampaki P, Ayyad A, Kockro RA, Perneczky A. Surgical complications after endoscopic transsphenoidal pituitary surgery. J Clin Neurosci 2009; 16 (06) 786-789
  • 10 Hendricks BL, Shikary TA, Zimmer LA. Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol Head Neck Surg 2016; 154 (02) 359-365
  • 11 Johnston PC, Kennedy L, Hamrahian AH. et al. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience. Pituitary 2017; 20 (04) 430-440
  • 12 Joshi SM, Cudlip S. Transsphenoidal surgery. Pituitary 2008; 11 (04) 353-360
  • 13 Yuan W. Managing the patient with transsphenoidal pituitary tumor resection. J Neurosci Nurs 2013; 45 (02) 101-107 , quiz E1–E2
  • 14 Laws Jr ER, Iuliano SL, Cote DJ, Woodmansee W, Hsu L, Cho CH. A benchmark for preservation of normal pituitary function after endoscopic transsphenoidal surgery for pituitary macroadenomas. World Neurosurg 2016; 91: 371-375
  • 15 Lund-Johansen M. Neurosurgical endocrinology, endocrinological neurosurgery and interdisciplinary work. World Neurosurg 2015; 83 (05) 765-766
  • 16 McLaughlin N, Kassam AB, Prevedello DM, Kelly DF. Management of Cushing's disease after failed surgery--a review. Can J Neurol Sci 2011; 38 (01) 12-21
  • 17 Melmed S. Pituitary medicine from discovery to patient-focused outcomes. J Clin Endocrinol Metab 2016; 101 (03) 769-777
  • 18 Melmed S, Casanueva F, Cavagnini F. et al. Consensus statement: medical management of acromegaly. Eur J Endocrinol 2005; 153 (06) 737-740
  • 19 Melmed S, Colao A, Barkan A. et al; Acromegaly Consensus Group. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 2009; 94 (05) 1509-1517
  • 20 Prevedello DM, Pouratian N, Sherman J. et al. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J Neurosurg 2008; 109 (04) 751-759
  • 21 Rajasekaran S, Vanderpump M, Baldeweg S. et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 2011; 74 (01) 9-20
  • 22 Singer PA, Sevilla LJ. Postoperative endocrine management of pituitary tumors. Neurosurg Clin N Am 2003; 14 (01) 123-138
  • 23 Swearingen B. Update on pituitary surgery. J Clin Endocrinol Metab 2012; 97 (04) 1073-1081
  • 24 Vargas G, Gonzalez B, Ramirez C. et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol 2015; 2015: 756069
  • 25 McLaughlin N, Martin NA, Upadhyaya P. et al. Assessing the cost of contemporary pituitary care. Neurosurg Focus 2014; 37 (05) E7
  • 26 Murad MH, Fernández-Balsells MM, Barwise A. et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2010; 73 (06) 777-791
  • 27 Villwock JA, Villwock M, Deshaies E, Goyal P. Significant increases of pituitary tumors and resections from 1993 to 2011. Int Forum Allergy Rhinol 2014; 4 (09) 767-770
  • 28 Little AS, Chapple K. Improved resource utilization is associated with high volume surgical centers, low complication rates, and shorter length of stay in patients undergoing transsphenoidal surgery for cushing's disease. Neurosurgery 2012; 71 (02) E548
  • 29 Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Mota JI. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas. J Neurosurg 2015; 123 (01) 31-38
  • 30 Patil CG, Lad SP, Harsh GR, Laws Jr ER, Boakye M. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus 2007; 23 (03) E7
  • 31 Raappana A, Koivukangas J, Ebeling T, Pirilä T. Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab 2010; 95 (09) 4268-4275
  • 32 Chowdhury T, Prabhakar H, Bithal PK, Schaller B, Dash HH. Immediate postoperative complications in transsphenoidal pituitary surgery: a prospective study. Saudi J Anaesth 2014; 8 (03) 335-341
  • 33 Bohl MA, Ahmad S, Jahnke H. et al. Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 2016; 78 (01) 84-90
  • 34 Bates PR, Carson MN, Trainer PJ, Wass JA. UK National Acromegaly Register Study Group (UKAR-2). Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 2008; 68 (01) 136-142
  • 35 Powell M, Grossman A. Quality indicators in pituitary surgery: a need for reliable and valid assessments. What should be measured?. Clin Endocrinol (Oxf) 2016; 84 (04) 485-488
  • 36 Kreutzer J, Fahlbusch R. Diagnosis and treatment of pituitary tumors. Curr Opin Neurol 2004; 17 (06) 693-703